Electronic health records have great potential to help clinicians better manage patients with chronic diseases, such as diabetes, asthma and obesity. Disease management tools include identification of at-risk patients, lab and results alerts, and condition-specific registries.
The ability of patients and providers to share blood pressure data through electronic health records is helping to track progress for Million Hearts, an initiative of the Department of Health and Human Services to prevent 1 million heart attacks and strokes by 2017 by controlling the blood pressure of 10 million Americans.
It's easy for most of us to remember those cataclysmic societal events after which it is universally intoned that "things will never be the same again." It may be a little more rare to remember those events which slide under the radar of most folks, but which have profound consequences nonetheless.
Electronic health records are supposed to play a pivotal role in the Obama administrations Precision Medicine Initiative which hopes to collect data from a million or more volunteers, serving as part of a national research cohort. But, according to Anne Wojcicki, CEO of direct-to-consumer genetic testing company 23andMe, self-reported data has more value than EHRs.
The National Institutes of Health is collaborating with the Defense Advanced Research Projects Agency and Food and Drug Administration to create miniature 3D models of living organs and tissues on microchips to test drug safety and efficacy more accurately and less costly than current methods.
Consumers using home health technologies will increase from 14.3 million worldwide in 2014 to 78.5 million by 2020, according to research firm Tractica.
A new IBM business unit launched last week to help physicians, researchers, insurers and patients use big data, analytics and mobile technology to achieve better health outcomes is being described by the companys chief executive officer as their moonshot in healthcare.
The Workgroup for Electronic Data Interchange, an advocacy organization and advisory body to the federal government, is studying issues related to genomic data exchange, particularly how it can improve care coordination.
Hospital chief information officers may believe they are responsible for patient engagement, but a recent survey of providers, CIOs and patients raises questions if the CIO is the right office to lead the effort.
Orlando Health and Florida Hospital dominate central Florida with a combined market share of about 80 percent, and both are trying to recruit physicians and establish themselves as leaders of accountable care.
In the opening keynote at the HIMSS15 conference on Monday, Walgreens President Alex Gourlay laid out his companys vision for creating a patient-centered pharmacy that leverages mobile healthcare and digital health technologies.
The Food and Drug Administration is fast-tracking qualifying medical devices to patients with life-threatening or irreversibly debilitating conditions that lack treatment and diagnostic options.
We have entered the era of the connected patient as shown by the Apple Watch and other wearable devices that gather data seamlessly and continuously. Along with mobile health applications, they promise to extend medical care further into peoples lives than ever before. This transformation will not happen, however, without providers investing in modern social, mobile, cloud and data science platforms that manage information from multiple streams and make it actionable.
There has been no shortage of recent news about health systems and technology developers exploiting the surge in consumer fitness technology. There has been a shortage, however, of clinically valid quantification of activity data--until now.
Following listening sessions held last year in five U.S. cities, the Robert Wood Johnson Foundation has issued recommendations on how health data can be collected, shared, protected, and translated in ways that are useful to consumers, organizations and communities nationwide.
An Apple HealthKit-compliant iOS app designed to help patients monitor and manage the symptoms of Chronic Obstructive Pulmonary Disease will be commercially available in the second half of 2015.